Interleukin-1 receptor antagonist gene (IL1RN) variants modulate the cytokine release syndrome and mortality of SARS-CoV-2

Mukundan Attur, Christopher Petrilli, Samrachana Adhikari, Eduardo Iturrate, Xiyue Li, Stephanie Tuminello, Nan Hu, Aravinda Chakravarti, David Beck, Steven B. Abramson
doi: https://doi.org/10.1101/2023.01.09.23284348

Article Information

doi 
https://doi.org/10.1101/2023.01.09.23284348
History 
  • January 11, 2023.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Mukundan Attur1,
  2. Christopher Petrilli2,
  3. Samrachana Adhikari3,
  4. Eduardo Iturrate2,
  5. Xiyue Li3,
  6. Stephanie Tuminello3,
  7. Nan Hu4,
  8. Aravinda Chakravarti2,4,
  9. David Beck2,4 and
  10. Steven B. Abramson2,#
  1. 1Division of Rheumatology, Department of Medicine, NYU Langone Orthopedic Hospital, NYU Langone Health, NY -10003
  2. 2Department of Medicine, NYU Grossman School of Medicine, NYU Langone Health, New York, NY -10016
  3. 3Division of Biostatistics, Department of Population Health, NYU Grossman School of Medicine, New York, NY-10016
  4. 4Center for Human Genetics and Genomics, NYU Grossman School of Medicine, New York, NY-10016
  1. ↵# Corresponding author; email: stevenb.abramson{at}nyulangone.org
Back to top
Posted January 11, 2023.
Download PDF

Supplementary Material

Data/Code
Email
Interleukin-1 receptor antagonist gene (IL1RN) variants modulate the cytokine release syndrome and mortality of SARS-CoV-2
Mukundan Attur, Christopher Petrilli, Samrachana Adhikari, Eduardo Iturrate, Xiyue Li, Stephanie Tuminello, Nan Hu, Aravinda Chakravarti, David Beck, Steven B. Abramson
medRxiv 2023.01.09.23284348; doi: https://doi.org/10.1101/2023.01.09.23284348
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area